Histopathology during the COVID-19 pandemic: resilience through adaptation and innovation.

Bracey T; Arif S; Ralte AM; Shaaban AM; Ganesan R

doi:10.1016/j.mpdhp.2020.12.003

Histopathology during the COVID-19 pandemic: resilience through adaptation and innovation.

Bracey T, Arif S, Ralte AM, Shaaban AM, Ganesan R

Diagnostic histopathology (Oxford, England) · 2021 · doi:10.1016/j.mpdhp.2020.12.003 · PMID:33391394 · PMC7772581

OA: gold

📄 Open PDF View on PubMed View at publisher

Abstract

Histopathology departments have adapted to the challenges posed by the COVID-19 pandemic by a variety of changes including working pattern alterations, technology adoptions and incorporation of techniques. This article summarizes these adaptations and provides references to guide pathologists through the continuing pandemic.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc: last seen: 2026-08-13T06:15:24.848197+00:00
unpaywall: last seen: 2026-08-14T06:25:32.811723+00:00